AI Summary

Seattle startup Lila Bio has been awarded a $3.65 million grant from the National Institutes of Health to develop a treatment for pulmonary hypertension that uses proteins designed with artificial‑intelligence tools. The project aims to target the disease’s underlying mechanisms rather than merely relieving symptoms. Research is presently confined to laboratory work and animal‑testing phases.

AI summaries can be wrong sometimes—always verify important details using the source article.